English | 简体中文 | 繁體中文 | 한국어 | 日本語
Thursday, 5 December 2013, 22:05 HKT/SGT
Share:
    

Source: Omnicare
Omnicare Increases Dividend, Share Repurchase Authorization
Additional Share Repurchase Authorization of $500 Million; Quarterly Dividend Increased 43% to $0.20 per Share

CINCINNATI, OH, Dec 5, 2013 - (ACN Newswire) - Omnicare, Inc. (NYSE:OCR), today announced an additional share repurchase program and a sizeable increase to its quarterly dividend, reflecting the Company's continued focus on returning capital to its stockholders.

Omnicare's board of directors authorized the Company to repurchase an additional $500 million of outstanding shares of its common stock from time to time through December 31, 2015. Year to date, Omnicare has repurchased 4.2 million shares for an aggregate purchase price of $220 million.

In addition, the Company's board of directors approved a quarterly cash dividend of $0.20 per share on the Company's common stock, to be paid on December 24, 2013, to all shareholders of record on December 16, 2013. The new quarterly dividend represents a 43 percent increase over the previous amount of $0.14 per share.

"Returning capital to stockholders is an important element of our capital allocation strategy," said John Workman, Omnicare's Chief Executive Officer. "With these substantial increases to both our share repurchase program and quarterly cash dividend, we are better positioned to redeploy our cash flows to the benefit of our stockholders."

About Omnicare

Omnicare, Inc., a Fortune 500 company based in Cincinnati, Ohio, provides comprehensive pharmaceutical services to patients and providers across North America. As the market-leader in professional pharmacy, related consulting and data management services for skilled nursing, assisted living and other chronic care institutions, Omnicare leverages its unparalleled clinical insight into the geriatric market along with some of the industry's most innovative technological capabilities to the benefit of its long-term care customers. Omnicare also provides key commercialization services for the bio-pharmaceutical industry through its Specialty Care Group. For more information, visit www.omnicare.com.

Contact:
Patrick C. Lee
+1-513-719-1507
patrick.lee@omnicare.com


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Omnicare via Globenewswire

Topic: General Announcement
Source: Omnicare

Sectors: Daily News
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Omnicare Related News
Sept 16, 2015 07:55 HKT/SGT
Omnicare Trust PIERS to Accrue Contingent Interest
Aug 19, 2015 07:35 HKT/SGT
Omnicare Announces Conversion Rate Adjustments for Convertible Notes
July 24, 2015 20:40 HKT/SGT
Omnicare Reports Second-Quarter 2015 Financial Results
June 20, 2015 06:05 HKT/SGT
Omnicare's Series A and Series B Trust PIERS to Accrue Contingent Interest
May 22, 2015 06:30 HKT/SGT
Omnicare Declares Quarterly Cash Dividend
More news >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575